newsRituximabB細胞枯渇
Early B-Cell Depletion Patterns Predict Long-Term Rituximab Outcomes and Refractory Disease in Rheumatoid Arthritis
By MedXY|Aug 20, 2026
High-sensitivity flow cytometry reveals that early plasmablast depletion predicts 5-year rituximab response in rheumatoid arthritis, while incomplete memory B-cell depletion signals poly-refractory disease.